Skip to content
Home/Companies/MedTech/Protip

Protip

MedTech·France·Active·10yr hold
Entry
2016
Hold
10yr
Status
Active

Who owns Protip?

Protip is a French MedTech company, currently owned by Seventure Partners since 2016.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Seventure Partners
Investor
Seventure Partners
Health for Life Capital · 2014 · VC

Key facts

HQFrance
SectorMedTech

More from Health for Life Capital

Other portfolio companies in the same fund.

Clinical Microbiomics
Active
Kainova Therapeutics
Kainova Therapeutics
Active
BiotechCanada· 2026
MaaT Pharma
MaaT Pharma
Active
BiotechFrance· 2026
Microbiotica
Microbiotica
Active
BiotechUK· 2026
Standing Ovation
Active
BiotechFrance· 2026
Sunrise
Sunrise
Active
MedTechBelgium· 2024

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Protip?

Protip is currently owned by Seventure Partners, through Health for Life Capital, since 2016.

When did Seventure Partners acquire Protip?

Seventure Partners acquired Protip in 2016.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue